<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Caffeine: Effects on reproductive outcomes in females
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Caffeine: Effects on reproductive outcomes in females
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Caffeine: Effects on reproductive outcomes in females
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert J Norman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Charles J Lockwood, MD, MHCM
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Seres, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen Eckler, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 30, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Caffeine is the most popular pharmacologically active substance consumed in the world. It is a stimulant that is often used to enhance mental alertness.
        </p>
        <p>
         Although there is no high-quality evidence that a modest level of caffeine consumption has adverse effects on fertility or pregnancy outcome, putative beliefs about a relationship between caffeine intake and adverse reproductive outcomes are common, and caffeine consumption is often perceived to be an unhealthy habit. The consumption of caffeinated beverages has been implicated in fertility problems, while consumption during pregnancy has been associated with an increased risk of miscarriage, congenital malformations, fetal growth restriction, stillbirth, and long-term behavioral effects in offspring. The biologic rationale proposed for these associations is caffeine's ability to accumulate in fetal tissues and produce diverse pharmacologic effects that could interfere with fetal growth and development [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         This topic will review the relationship between caffeine intake and reproductive issues in females. The physiologic effects of caffeine and caffeinated beverages and the effects of caffeine on specific disease processes, including insulin resistance, cancer, cardiovascular disease, and mortality are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1553.html" rel="external">
          "Cardiovascular effects of caffeine and caffeinated beverages"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5369.html" rel="external">
          "Benefits and risks of caffeine and caffeinated beverages"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         In this topic, when discussing study results, we will use the terms "woman/en" or "patient(s)" as they are used in the studies presented. We encourage the reader to consider the specific counseling and treatment needs of transgender and gender-expansive individuals.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          SOURCES OF CAFFEINE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Caffeine originates in more than 60 plants, occurs naturally in various food products and beverages (including coffee, tea, chocolate, cocoa products, colas), and is added to some soft drinks and most "energy" drinks. Caffeine is also present in some prescription and over-the-counter medications, such as cold and flu remedies, allergy and headache treatments, diet pills, diuretics, and stimulants. Increasingly, caffeine is now present as an additive in snack foods, sports performance supplements, and dietary supplements. Examples of the caffeine content of various products can be found online (eg,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cspinet.org%2Fcaffeine-chart&amp;token=F2fTJXWTbAdqtiUVhUGfETonFbU9J8e0isoGIp%2FtZXVhhzwc2z2zYwFU7hTmtZz7&amp;TOPIC_ID=406" target="_blank">
          http://www.cspinet.org/new/cafchart.htm
         </a>
         ) and in the table (
         <a class="graphic graphic_table graphicRef79304" href="/z/d/graphic/79304.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Coffee, tea, cocoa and carbonated soft drinks are the main sources of caffeine intake. Consumption varies throughout the world, and is influenced by culture, individual preferences, availability, and advertising. Coffee contains 50 to 70 percent more caffeine than tea and other products, accounting for the main source of caffeine in many populations.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          CAFFEINE CONSUMPTION IN WOMEN OF REPRODUCTIVE AGE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Estimates of daily caffeine intake vary widely, both worldwide and within individual countries, due to the many significant difficulties in ascertaining caffeine consumption (
         <a class="graphic graphic_table graphicRef79304" href="/z/d/graphic/79304.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Quality of existing evidence and methodologic considerations'
         </a>
         below). In a study of data from a United States Department of Agriculture (USDA) Survey of Food Intakes by Individuals, caffeine was consumed by 89 percent of women aged 18 to 34 years and their average intake was 164 mg per day [
         <a href="#rid3">
          3
         </a>
         ]. In a study from the United Kingdom, the average daily caffeine intake of women of childbearing age was estimated to be 174 mg per day, with up to 18 percent consuming more than 300 mg per day [
         <a href="#rid4">
          4
         </a>
         ]. A study from Japan reported the mean caffeine intake of women aged 30 to 39 years was 213 mg/day, and 7 percent consumed more than 400 mg/day [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Although most individuals reduce their caffeine intake during pregnancy, likely in part because of nausea, pregnant persons have been reported to consume an average of 60 to 125 mg of caffeine per day [
         <a href="#rid3">
          3,6
         </a>
         ], and 10 to 15 percent consumed more than 160 to 200 mg daily [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          PHARMACOKINETICS, METABOLISM, AND PHYSIOLOGIC EFFECTS
         </span>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          General population
         </span>
         <span class="headingEndMark">
          —
         </span>
         Caffeine (methylated xanthine 1,3,7-trimethylxantine) is a highly soluble compound that readily crosses cell membranes throughout the body. It is rapidly absorbed in the stomach and small intestine and can be detected in human tissues 30 to 45 minutes after ingestion, with peak blood concentration reached within two hours. Clearance values are 1 to 3 mL/kg/min in both men and women after low caffeine intake; however, clearance is diminished with higher doses, largely because of saturable metabolism of caffeine metabolites that accumulate in plasma and reduce caffeine clearance [
         <a href="#rid2">
          2
         </a>
         ]. The volume of distribution of caffeine is 0.7 to 1.3 L/kg and elimination half-life is 4.1 to 6.4 hours. Caffeine is metabolized in the liver by the cytochrome P450 family. Cytochrome P450 1A2 (CYP 1A2) is the predominant isoform, accounting for 95 percent of primary caffeine metabolism [
         <a href="#rid8">
          8
         </a>
         ]. CYP 2E1 and CYP 1B1 may also make a minor contribution to the primary metabolism of caffeine [
         <a href="#rid2">
          2
         </a>
         ]. Caffeine metabolism depends on numerous genetic and environmental factors. Thus, studies attempting to assess the impact of caffeine exposure may be further confounded by genotype in addition to caffeine dose [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1553.html" rel="external">
          "Cardiovascular effects of caffeine and caffeinated beverages", section on 'Pharmacokinetics'
         </a>
         .)
        </p>
        <p>
         The primary metabolites of caffeine, paraxanthine (1,7 dimethylxanthine),
         <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">
          theophylline
         </a>
         (1,3 dimethylxanthine) and theobromine (3,7 dimethylxanthine), share many of the biologic activities of caffeine and also occur independently in natural products [
         <a href="#rid10">
          10
         </a>
         ]. Paraxanthine is the main metabolite in humans and is present in coffee beans; theophylline is a significant xanthine in tea leaves; and theobromine, the weakest of xanthines, is present in cacao beans. Further metabolism leads to the formation of monomethylxanthines and methyluracils. Caffeine is excreted by the kidneys, mainly in the form of different metabolites; only 0.5 to 2.0 percent is excreted unchanged in urine [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2705278528">
         <span class="h2">
          Individual variations in caffeine metabolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clearance rate of caffeine varies among individuals and depends on factors affecting cytochrome P450 enzymes, particularly genetic polymorphisms; smoking; and exposure to other compounds that are metabolized by the same enzyme. As a result, despite equivalent caffeine intake, slow metabolizers have higher caffeine concentrations and may be at higher caffeine-related risk for loss of pregnancy than fast metabolizers [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Maternal and fetal kinetics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Caffeine and its metabolites readily cross the placenta and can be found in substantial quantities in the amniotic fluid and fetal blood [
         <a href="#rid14">
          14
         </a>
         ]. Maternal caffeine metabolism declines significantly during pregnancy; the half-life increases threefold in the third trimester, reaching a t
         <sub>
          1/2
         </sub>
         of 11.5 to 18 hours [
         <a href="#rid15">
          15,16
         </a>
         ]. The fetus metabolizes caffeine very slowly, mainly due to immaturity of caffeine-metabolizing hepatic microsome enzymes and lack of CYP 1A2 activity in the placenta (the placenta does not metabolize caffeine) [
         <a href="#rid1">
          1
         </a>
         ]. Therefore, even low maternal caffeine consumption can be expected to lead to prolonged fetal caffeine exposure, particularly when the mother is a genetically slow caffeine metabolizer. Infants of smokers have lower umbilical cord blood caffeine concentrations and higher concentrations of caffeine metabolites than infants of nonsmokers, reflecting faster caffeine metabolism in smokers [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Caffeine consumption may increase release of circulating catecholamines [
         <a href="#rid17">
          17,18
         </a>
         ], which could cause uteroplacental vasoconstriction leading to fetal hypoxia, but an increase in catecholamines has not been reported consistently [
         <a href="#rid19">
          19
         </a>
         ]. Increases in maternal homocysteine, cholesterol, and cellular cyclic adenosine monophosphate (cAMP) concentrations [
         <a href="#rid20">
          20-24
         </a>
         ] and changes in maternal reproductive hormone levels [
         <a href="#rid25">
          25
         </a>
         ] have also been reported, and potential adverse effects on pregnancy outcome have been hypothesized but have not been proven.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          QUALITY OF EXISTING EVIDENCE AND METHODOLOGIC CONSIDERATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Examining the association between caffeine consumption and adverse reproductive outcomes presents a considerable challenge. The consistency and quality of available data have generally been poor. Most studies have methodologic shortcomings and were based on epidemiologic research designs usually classified as level III or low quality evidence (ie, comparative studies with concurrent controls but allocation not randomized, cohort studies, case-control studies, or interrupted time series with a control group) [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         There are many potential reasons for inconsistent outcomes among studies, including but not limited to [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inaccurate estimation of caffeine consumption
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recall bias due to retrospective assessment of caffeine intake
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure to allow for individual variations in caffeine metabolism
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inadequate control of confounding factors
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Selection bias
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chemicals other than caffeine in dietary products, which may contribute to the observed outcome
        </p>
        <p>
        </p>
        <p>
         Comprehensive reviews of these methodologic issues are available elsewhere [
         <a href="#rid1">
          1,27,28
         </a>
         ], and will be reviewed briefly here. In particular, caffeine consumption is likely to be lower in early than late pregnancy because of early pregnancy nausea [
         <a href="#rid29">
          29
         </a>
         ]. The majority of existent studies primarily capture the short-term effects of caffeine by assessing consumption in the period shortly before the studied reproductive event or in individual trimesters rather than throughout pregnancy, although many health-related conditions are likely to have multifactorial causes and a long natural history. It has been difficult to document the long-term effects of caffeine because many new caffeinated products appear in the marketplace and consumption patterns change as a result of dietary advice from a variety of experts.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Assessment of caffeine intake
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assessment of caffeine consumption is methodologically challenging due, in part, to the wide variation of caffeine content in beverages and large differences in serving sizes. The amount of caffeine varies according to source (coffee, tea, chocolate, soft drink), portion size (eg, cup size), brewing method (for coffee and tea), and brand [
         <a href="#rid30">
          30
         </a>
         ]. A standard cup of coffee is often assumed to provide 100 mg of caffeine; however, an analysis of caffeine content of different coffees from various coffee shops revealed variations of 72 to 130 mg/cup [
         <a href="#rid31">
          31
         </a>
         ]. For espresso, an analysis of caffeine content reported caffeine content of 200 to 322 mg/cup in 20 commercially available espresso products [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         Coffee is reported as the only source of caffeine in 19 percent of pregnant caffeine consumers, with 26 percent of caffeine intake solely from other non-coffee dietary sources [
         <a href="#rid33">
          33,34
         </a>
         ]. Therefore, using coffee consumption as a proxy for caffeine intake leads to underestimation of caffeine consumption. The majority of studies on caffeine and reproductive outcomes neither made a comprehensive analysis of intake of all food, drinks, and drugs containing caffeine, nor carefully accounted for the variation of caffeine content from individual portion size, brand, or preparation method of these foods and drinks.
        </p>
        <p>
         Furthermore, most epidemiologic studies have relied on indirect data, such as self-reported intake of caffeine, instead of laboratory assessment of biomarkers. The biomarkers of caffeine exposure (caffeine and its metabolites in blood, urine, and saliva) are of limited use in large population samples, are highly dependent on the timing of the last caffeine intake, and primarily indicate recent consumption rather than long-term exposure [
         <a href="#rid7">
          7,35
         </a>
         ].
        </p>
        <p>
         Although caffeine is detectable in amniotic fluid and in the nails of exposed newborns, studies have not used these types of assays to monitor in utero caffeine exposure.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Recall bias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recall bias refers to differential recall between cases and controls and is of concern because it distorts the internal validity of studies using self-reported data. It affects studies (both retrospective and prospective) in which assessment of caffeine consumption is determined after, rather than before, the occurrence of the health outcome of interest. Patients who have had an adverse event may be more likely to remember perceived unhealthy habits and associate their consumption of coffee with the adverse event, and thus may overestimate their past caffeine consumption compared with patients who have not experienced an adverse event.
        </p>
        <p>
         The importance of recall bias was highlighted by a study that found the correlation between modest caffeine consumption and pregnancy loss disappeared when pregnant women were interviewed about caffeine consumption before, rather than after, they had miscarried [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Potential confounders in studying caffeine consumption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Heavy coffee consumption tends to be strongly associated with increased age, cigarette smoking, alcohol consumption, a less health conscious lifestyle, and lower educational level and household income [
         <a href="#rid2">
          2
         </a>
         ]. Other potential confounders include ethnicity, stress, and sleeping pattern. Trying to establish the independent health effects of coffee consumption by adjusting for these potential confounders is difficult and can be inaccurate since their assessment is also affected by measurement error.
        </p>
        <p>
         Nausea and other symptoms of a viable early pregnancy are sometimes called the "pregnancy signal." A particular concern in studies of the effects of caffeine intake during pregnancy is that pregnancy related nausea is common and an important confounding factor [
         <a href="#rid37">
          37
         </a>
         ]. Nausea in early pregnancy tends to cause dietary changes, such as an aversion to coffee, but is also strongly predictive of fetal survival, presumably because nausea reflects hormonal changes that support continued pregnancy [
         <a href="#rid38">
          38
         </a>
         ]. For this reason, there has been a concern that the lower caffeine consumption and more favorable pregnancy prognosis among women with nausea compared with those who do not have nausea result in an artificial positive association between low caffeine consumption and better pregnancy outcome. Well-designed studies of caffeine intake and pregnancy outcome attempt to control for the presence or absence of pregnancy signal symptoms in their subjects.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Selection bias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many of the studies on the effect of caffeine on reproductive adversity are based on data obtained from preconception counseling and prenatal health services. The patients attending these services are likely to be more health conscious, which may be associated with lower coffee consumption and thus lead to selection bias, but this would also tend to reduce the associated odds ratios.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Other components of caffeinated beverages that may contribute to health effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Coffee, tea, and cocoa products contain hundreds of compounds other than caffeine that may contribute to the observed health effects of caffeine consumption [
         <a href="#rid39">
          39
         </a>
         ]. In addition, coffee and black tea are often consumed with milk or a creamer. Non-dairy creamers contain partially hydrogenated oils that, when used in large amounts, could be a significant dietary source of trans fatty acids, which may have independent adverse effects on reproduction. Trans fatty acids may interfere with the desaturation and elongation of n-3 (omega-3) fatty acids. These are important for the prevention of heart disease and possibly some complications of pregnancy.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          EFFECTS OF CAFFEINE ON REPRODUCTIVE OUTCOMES
         </span>
        </p>
        <p class="headingAnchor" id="H10028135">
         <span class="h2">
          Animal and in vitro studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies in animals can overcome many of the methodologic limitations of studies in humans, but pose additional methodologic issues that prevent extrapolation to humans. First, humans are highly unlikely to consume the high doses of caffeine used in animal studies. Second, although many metabolic and pharmacokinetic factors related to caffeine are similar in humans and animals, there is not a direct correlation between teratogenic effects in animals and in humans, and the dose/anomaly relationship may vary between the species. Finally, in some animal studies, caffeine intake is by intravenous or intraperitoneal infusion or gavage feeding, rather than by oral consumption in food/drink over the course of a day, as in humans. This difference may result in different effects in laboratory animals versus humans. Indeed, when animals receive caffeine doses typically consumed by humans, caffeine is not mutagenic, oncogenic, or cytotoxic [
         <a href="#rid27">
          27
         </a>
         ]. However, it is possible that subteratogenic doses of caffeine may have synergistic detrimental effects with other therapeutic agents consumed by pregnant women.
        </p>
        <p>
         Some examples of findings from animal studies are summarized below:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In rodents, a teratogenic effect was demonstrated at extremely high caffeine doses (100 to 330 mg/kg); limb deficiencies, cleft palate, and neural tube defects (NTDs) were among the most frequently observed caffeine-induced congenital malformations [
         <a href="#rid40">
          40-43
         </a>
         ]. The caffeine-induced NTD phenotype has been demonstrated by others in various animal models [
         <a href="#rid44">
          44-47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Caffeine injected into chicken eggs affected monoamine neurotransmitter synthesis in chick embryos and was not metabolized in embryonic brains, which led to caffeine accumulation and magnification of the adverse effects [
         <a href="#rid44">
          44
         </a>
         ]. These changes have been implicated in subsequent neurobehavioral or neurophysiologic deficiencies [
         <a href="#rid48">
          48-50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rodents given a large bolus or parenteral dose of caffeine are at increased risk of growth restriction in their pups; however, no effect on birth weight has been observed when large doses of caffeine were consumed over the course of the day in drinking water [
         <a href="#rid27">
          27
         </a>
         ]. Caffeine boluses also delayed conception and decreased placental weight and gain in maternal bodyweight; these effects were dose dependent [
         <a href="#rid51">
          51
         </a>
         ]. Using a dose-conversion correlation between humans and rats, the lowest dose of caffeine given to pregnant rats and associated with the above effects appeared to be equivalent to 3.2 mg/kg per day in humans, which is equivalent to consumption of 1.5 to 2.2 cups of coffee by a 70 kg woman.
        </p>
        <p>
        </p>
        <p>
         Several basic research studies have assessed the effect of caffeine on trophoblast biology in vitro and suggested molecular mechanisms for deleterious caffeine effect on pregnancy outcomes [
         <a href="#rid52">
          52-54
         </a>
         ]. A detailed discussion of these mechanisms is beyond the scope of this topic.
        </p>
        <p class="headingAnchor" id="H10028430">
         <span class="h2">
          Human studies
         </span>
        </p>
        <p class="headingAnchor" id="H4159863478">
         <span class="h3">
          Summary
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although there is ongoing controversy regarding the safety of caffeine consumption in females planning to conceive or in those who are pregnant, most studies on the topic, and resultant recommendations, provide reassurance that small to moderate amounts of caffeine are unlikely to harm the pregnancy (
         <a class="graphic graphic_table graphicRef134407" href="/z/d/graphic/134407.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid55">
          55-61
         </a>
         ]. Higher levels of maternal caffeine consumption (above 300 mg per day) have generally been associated with adverse reproductive outcomes, while the impact of lower levels of consumption is less clear. Although earlier studies had suggested lower levels of caffeine intake had little to no impact [
         <a href="#rid27">
          27,28
         </a>
         ], subsequent reviews reported conflicting results, including potential for harm. Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2015 systematic review that included one trial comparing the effects of caffeinated coffee intake with decaffeinated coffee use on pregnancy outcomes demonstrated that reducing the caffeine intake in high coffee consumers by an average of 182 mg per day during the second and third trimesters did not affect birth weight or length of gestation [
         <a href="#rid62">
          62
         </a>
         ]. The authors concluded there was insufficient evidence to confirm or refute the effect of caffeine avoidance on pregnancy outcomes and neonatal health.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2017 comprehensive and structured systematic review of 381 studies published from 2001 to June 2015 found that, for healthy pregnant women, consumption of up to 300 mg of caffeine per day was generally not associated with adverse reproductive or developmental effects [
         <a href="#rid63">
          63
         </a>
         ]. It emphasized the need to support a shift in caffeine research to a better quantitative characterization of interindividual variability.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A 2020 narrative review of 42 findings from 37 observational studies, all published since 2000 and many used in the 2017 review, concluded that caffeine consumption was significantly associated with negative outcomes, including pregnancy loss (miscarriage), stillbirth, low birth weight, and small for gestational age [
         <a href="#rid64">
          64
         </a>
         ]. Negative outcomes were identified at lower levels of consumption and increased in a dose-dependent manner. Even moderate caffeine consumption (200 mg per day) was alleged to be unsafe. As discussed above, the effect of extraneous variables and possible misclassification of exposure and outcome variables remain limitations of observational studies. Evaluation of the explanation for the difference in conclusions between the 2017 and 2020 studies is pending but highlights the need for caution in advising women who are planning to become pregnant or are in the early stages of pregnancy. (See
         <a class="local">
          'Quality of existing evidence and methodologic considerations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         A list of the caffeine content of beverages and foods is available in the table (
         <a class="graphic graphic_table graphicRef79304" href="/z/d/graphic/79304.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H3722616963">
         <span class="h3">
          Fertility
         </span>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h4">
          Fecundability
         </span>
         <span class="headingEndMark">
          —
         </span>
         When adequately adjusted for other lifestyle factors related to fertility, particularly maternal age, cigarette smoking, and alcohol intake, the bulk of evidence does not support a clear detrimental effect of caffeine on fecundability (ie, probability of conception within a non-contracepting menstrual cycle) [
         <a href="#rid28">
          28,65,66
         </a>
         ].
        </p>
        <p>
         In 1988, a study of couples who failed to conceive within the first three months of trying to become pregnant observed that consumption of at least one cup of coffee, two cups of tea, or 2.5 glasses of cola daily was associated with a marked reduction in fecundability in subsequent cycles compared with women who consumed less caffeine, and a dose response effect was noted [
         <a href="#rid67">
          67
         </a>
         ]. This study prompted further investigation of a possible relationship between caffeine and subfertility. Although some retrospective studies have also observed reduced fecundability, particularly with high caffeine intake [
         <a href="#rid68">
          68,69
         </a>
         ], most prospective epidemiologic studies have not found a statistically significant association between caffeine consumption and fecundability [
         <a href="#rid70">
          70-75
         </a>
         ]. One of these studies was particularly strong because it was the first to use daily, prospective information on caffeine intake and prospectively ascertained pregnancies, including subclinical pregnancies, while controlling for frequency of intercourse, smoking, age, body mass index, frequency of unprotected intercourse, and alcohol intake [
         <a href="#rid71">
          71
         </a>
         ]. Another observed decreased fecundability among women who consumed sodas and increased fecundability among women who drank tea [
         <a href="#rid75">
          75
         </a>
         ]. This indicates that a caffeine exposure variable that does not take into account the specific source may not be appropriate and suggests that these associations may reflect unmeasured confounding by diet or other lifestyle factors.
        </p>
        <p>
         The relationship between caffeine consumption and success of in vitro fertilization (IVF) has not been studied as extensively. In one study, caffeine intake by women undergoing IVF did not affect rates of oocyte retrieval, fertilization, embryo development, or pregnancy rate when caffeine consumption was assessed just before or during the treatment cycle [
         <a href="#rid76">
          76
         </a>
         ]. However, lifetime caffeine intake in the same group of women seemed to have a negative effect on achieving and maintaining pregnancy. This was a small study and the confidence intervals around the point estimates were wide. Another study concluded caffeine consumption did not affect overall IVF pregnancy rates; however, higher coffee/tea consumption was negatively associated with the number of oocytes retrieved and the number of good quality embryos [
         <a href="#rid77">
          77
         </a>
         ]. Caffeine was detected in follicular fluid; its actions there are unknown.
        </p>
        <p>
         The available data are not definitive; therefore, reproductive endocrinologists suggest that it may be prudent for women who are having difficulty conceiving to limit caffeine consumption to less than 200 to 300 mg per day, in addition to eliminating tobacco use, decreasing alcohol consumption, and other sensible lifestyle actions [
         <a href="#rid58">
          58,65,66,78
         </a>
         ].
        </p>
        <p>
         A 2017 systematic review demonstrated lack of consistency among studies reporting on effect of caffeine on male fertility. Most observational studies on the topic did not observe significant alterations in semen parameters or consistent changes in sperm DNA integrity, although it is widely acknowledged that semen quality has only limited predictive value for pregnancy [
         <a href="#rid79">
          79
         </a>
         ]. Another systematic review that synthesized the available evidence on effect of nutrients on male fertility demonstrated that, while the data on association of caffeine and low semen quality are inconclusive, high caffeine intake in male partners has a negative influence on the chance of pregnancy or fertilization rates [
         <a href="#rid80">
          80
         </a>
         ]. Likewise, a prospective cohort study on effects of environmental exposures on reproductive health in subfertile couples (EARTH Study), demonstrated that male caffeine intake was negatively associated with live birth following assisted reproductive technology treatments, while having little effect on semen quality [
         <a href="#rid81">
          81
         </a>
         ]. In this study, adjusted live birth rate was 19 percent in couples with a male partner consuming above 272 mg caffeine/day versus 55 percent in couples with a male partner consuming below 99 mg caffeine/day [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h4">
          Pregnancy loss (miscarriage)
         </span>
         <span class="headingEndMark">
          —
         </span>
         As discussed in detail below, studies assessing impact of maternal caffeine consumption on risk of pregnancy conflict, which makes patient counseling challenging. Additional prospective high-quality research is required to confirm or refute the direct association.
        </p>
        <p>
         A 2011 systematic review of both human and animal studies of the risk of spontaneous abortion from caffeine exposure concluded there was fair to good evidence that consumption of caffeinated beverages during pregnancy at a level ≤5 to 6 mg/kg body weight/day does not increase the risk of spontaneous abortion [
         <a href="#rid27">
          27
         </a>
         ]. Although high caffeine intake in some animal studies increased the risk minimally, even a woman who consumed 10 cups of coffee over a period of 8 to 10 hours (approximately 1000 mg of caffeine) would not reach this harmful level of intake.
        </p>
        <p>
         Findings among the 17 epidemiologic studies in this review were inconsistent and many studies did not observe an association at any level of reported exposure [
         <a href="#rid27">
          27
         </a>
         ]. Studies that noted a link between caffeine intake and spontaneous abortion generally reported a dose-response relationship, but differed in their conclusions about a threshold for a safe amount of caffeine consumption. An increased risk of spontaneous abortion generally was not observed until self-reported intake levels were ≥3 cups or ≥300 mg caffeine per day. A study using an objective assessment of caffeine exposure, serum paraxanthine concentration, observed an increased risk beginning at caffeine doses ≥600 mg [
         <a href="#rid82">
          82
         </a>
         ]. In addition, an analysis within the Danish national birth cohort, which included 565 women who consumed a prescription diet drug (Letigen) containing 200 mg of caffeine per pill (ie, approximately 600 mg/treatment day) periconceptionally, found no association between miscarriage and high-dose caffeine [
         <a href="#rid83">
          83
         </a>
         ]. In contrast, a prospective study that recruited 344 couples before conception and followed them through the first seven weeks of gestation reported an association between early miscarriage and consumption of &gt;2 daily caffeinated beverages by either parent [
         <a href="#rid84">
          84
         </a>
         ]. Also, a prospective cohort study of 5132 Danish women with spontaneous pregnancy demonstrated a small increased risk of spontaneous miscarriage with caffeine consumption above 100 mg/day in early pregnancy, although preconceptional consumption did not seem to increase the risk [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
         The methodologic issues and limitations previously discussed apply to the association reported in these studies, and include confounding by the inverse relationship between maternal nausea and both coffee consumption and miscarriage rate; recall bias; and imprecise ascertainment of caffeine intake [
         <a href="#rid36">
          36,38
         </a>
         ]. Other potentially distorting factors include using controls that were not well-matched for gestational age to the study population, lack of ascertainment of the multiple known causes of abortion, a tendency to confuse induced terminations with spontaneous abortions, and inadequate adjustment for multiple known confounders [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1293549523">
         <span class="h3">
          Fetal outcomes
         </span>
        </p>
        <p class="headingAnchor" id="H1893931654">
         <span class="h4">
          General impact
         </span>
         <span class="headingEndMark">
          —
         </span>
         The physiologic effects on the fetus of caffeine exposure have not been studied extensively in human pregnancy. Higher maternal plasma caffeine levels appear to be associated with a longer duration of fetal arousal, but fetal tolerance to caffeine exposure also appears to occur [
         <a href="#rid86">
          86-88
         </a>
         ]. Other fetal effects possibly related to maternal caffeine consumption include increased fetal heart rate variability, lower basal heart rate [
         <a href="#rid86">
          86,89
         </a>
         ], and increased fetal breathing activity [
         <a href="#rid88">
          88,89
         </a>
         ]. An increase in beat to beat variability and accelerations of the fetal heart rate following maternal intake of even one cup of espresso coffee (60 mg caffeine) or 30 g of "dark" chocolate (70 percent cocoa) in the third trimester has been attributed to the pharmacologic action of theobromine, present in coffee and in chocolate [
         <a href="#rid90">
          90
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1287057">
         <span class="h4">
          Congenital anomalies
         </span>
         <span class="headingEndMark">
          —
         </span>
         The overall body of evidence remains reassuring that low levels of maternal caffeine consumption are unlikely to increase the risk of congenital anomalies. Although some epidemiologic studies have reported an association between caffeine intake and certain congenital anomalies, the results should be interpreted with caution due to the methodologic flaws of these studies (eg, lack of correction for multiple comparisons, poor ascertainment of caffeine intake, etiologic heterogeneity for some malformations, biased exposure data, biased ascertainment of congenital anomalies) or because the findings were inconsistent with basic teratologic principles (eg, lack of dose effect, lack of increasing risk with increasing exposure, lack of consistent association with a specific defect or constellation of defects).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Unlikely to increase risk
         </strong>
         – Several narrative reviews and a systematic review concluded that caffeine is unlikely to cause congenital anomalies at doses consumed by humans (eg, fractional doses totaling &lt;5 mg/kg body weight/day) [
         <a href="#rid27">
          27,28,91,92
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Possible increased risk but no evidence of dose-response
         </strong>
         – The US National Birth Defects Study (NBDPS), 1997-2011, compared prepregnancy and first-trimester caffeine exposure (by patient self-report) for children with congenital anomalies (n = 30,285) with an unaffected control group (n = 11,502) and reported increased risk of some anomalies for both low (10 to &lt;100 mg/day) to moderate 100 to &lt;200 mg/day) and high (≥300 mg/day) levels of prepregnancy caffeine consumption [
         <a href="#rid93">
          93
         </a>
         ]. For the anomalies with increased adjusted odds ratios, similar elevations were seen across all levels of caffeine consumption, which indicates that a dose-response relationship was not observed. We and the study authors believe this analysis further confirms previous analyses demonstrating a lack of evidence for a meaningful association between maternal caffeine consumption and the studied congenital anomalies.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h4">
          Low birth weight
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although observational and cohort studies reported conflicting data on the impact of caffeine on birth weight [
         <a href="#rid27">
          27,94-102
         </a>
         ], two meta-analyses found that maternal caffeine intake during pregnancy was associated with a higher risk of delivering low birth weight infants (defined as birth weight less than 2500 gm, regardless of gestational age) as compared with the reference group (no or very low caffeine intake) [
         <a href="#rid103">
          103,104
         </a>
         ]. The risk of low birth weight increased as the maternal caffeine intake increased. In the dose-response analysis, each 100 mg per day increment in maternal caffeine intake was associated with a 3 to 13 percent higher risk of low birth weight, which further supports the current recommendation to minimize caffeine intake during pregnancy [
         <a href="#rid103">
          103,104
         </a>
         ]. (See
         <a class="local">
          'Recommendations of societies'
         </a>
         below.)
        </p>
        <p>
         However, a limitation of observational studies is that they cannot or may inadequately control for important risk factors for low birth weight, particularly smoking [
         <a href="#rid28">
          28,78,91
         </a>
         ]. The only randomized double blind trial that analyzed the effect of reducing caffeine intake on birth weight and length of gestation found that reducing caffeine intake by greater than 50 percent had no significant effect on these outcomes [
         <a href="#rid105">
          105
         </a>
         ]. In this trial, 1207 pregnant women who drank at least three cups of coffee per day were randomly assigned to receive unmarked jars of caffeinated or decaffeinated instant coffee for consumption after 20 weeks of gestation. Mean caffeine intake in the decaffeinated and caffeinated coffee groups was 117 and 317 mg/day, respectively. Mean birth weight and mean length of gestation were similar for women in the decaffeinated and caffeinated coffee groups (mean birth weight 3519 versus 3539 grams; mean length of gestation 279.3 versus 280.2 days) [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
         In light of these conflicting data, we advise women of the possible detrimental impact of caffeine consumption on fetal growth, although restricted growth is unlikely to be associated with moderate (200 to 300 mg/day) caffeine consumption; this approach is consistent with expert opinion [
         <a href="#rid2">
          2
         </a>
         ]. However, lower amounts of caffeine consumption may be associated with small but statistically significant decreases in birth weight that do not meet the definition of low birth weight [
         <a href="#rid106">
          106
         </a>
         ]. The clinical significance of small reductions in birth weight at term is not known.
        </p>
        <p class="headingAnchor" id="H1287261">
         <span class="h4">
          Preterm delivery
         </span>
         <span class="headingEndMark">
          —
         </span>
         A 2010 systematic review and meta-analysis that combined 15 cohort and 7 case-control studies did not find a significant association between maternal caffeine intake anytime in pregnancy and preterm birth [
         <a href="#rid107">
          107
         </a>
         ]. The lack of association was observed when comparing "any" versus "no" caffeine consumption and for "high" versus "low/no" caffeine consumption. For the highest versus the lowest level of caffeine intake (or no intake) during the first, second, and third trimesters, the odds ratios for preterm birth in cohort studies were 1.11 (95% CI 0.96-1.28), 1.10 (95% CI 1.01-1.19), and 1.08 (95% CI 0.93-1.27), respectively. For case-control studies, the odds ratios were 1.07 (95% CI 0.84-1.37), 1.17 (95% CI 0.94-1.45), and 0.94 (95% CI 0.79-1.12), respectively. Subsequent studies have reported mixed outcomes regarding risk of preterm birth, defined as delivery less than 37 weeks gestation, and caffeine exposure, but some studies were limited by small sample size [
         <a href="#rid62">
          62,102
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h4">
          Fetal death
         </span>
         <span class="headingEndMark">
          —
         </span>
         A systematic review of observational studies that examined the association between any source of exposure to caffeine from food in pregnancy and fetal mortality concluded that "the small number of publications, methodologic limitations, inaccurate exposure assessment in all the studies, overall risks only marginally significant in most cases, and the possibility of publication bias preclude stating with certainty that caffeine consumption is actually associated with fetal death" [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2892679647">
         <span class="h3">
          Maternal outcomes
         </span>
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h4">
          Gestational diabetes mellitus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consistent with epidemiologic studies in nonpregnant individuals reporting reduced risk of type 2 diabetes mellitus with long-term coffee consumption, low-dose coffee consumption during pregnancy appears to reduce the risk of gestational diabetes [
         <a href="#rid109">
          109-111
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5369.html" rel="external">
          "Benefits and risks of caffeine and caffeinated beverages", section on 'Type 2 diabetes mellitus'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective cohort study, periconceptional moderate caffeine intake from coffee appeared to protect against development of gestational diabetes mellitus (GDM; adjusted RR 0.50, 95% CI 0.29-0.85); there was no risk reduction associated with consumption of decaffeinated coffee or caffeinated tea or soda [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similarly, a population-based cohort study including over 71,000 singleton pregnancies in nondiabetic Danish women suggested that moderate first-trimester coffee and tea intake was not associated with increased risk of GDM and possibly had a protective effect [
         <a href="#rid110">
          110
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Paradoxically, several studies have shown that exposure to caffeine in experimental settings mildly reduced insulin sensitivity in humans [
         <a href="#rid112">
          112-114
         </a>
         ]. This may be due to combination of an indirect effect of caffeine via increasing levels of circulating epinephrine or to direct antagonism of adenosine receptors. Overall, the effect of caffeine on insulin resistance appears to be mild and has been mainly related to acute exposure. Moreover, the researchers in these studies predominantly implemented alkaloid caffeine, which may cause a different physiologic response than caffeine from dietary sources. The significance of caffeine's acute effect on the physiologic release of insulin in the natural setting, as well as the degree of tolerance to its metabolic effects during chronic consumption, remains unclear [
         <a href="#rid115">
          115
         </a>
         ]. Pregnant women in whom there are physiologic changes in glucose metabolism and a pregnancy-induced state of peripheral insulin resistance may be more likely to show the acute effects of caffeine observed in experimental settings. A retrospective study on banked blood samples of 251 women in the second trimester (mean gestational age of 20.3 weeks) showed a positive association between the risk of insulin resistance (estimated by homeostasis model assessment) and higher levels of caffeine and its metabolite paraxanthine in the blood [
         <a href="#rid116">
          116
         </a>
         ]. Caffeine concentrations &gt;266 ng/mL and paraxanthine concentrations &gt;392 ng/mL were associated with threefold higher odds of having higher insulin resistance [
         <a href="#rid116">
          116
         </a>
         ]. The clinical significance of these findings was not studied and requires further investigation.
        </p>
        <p class="headingAnchor" id="H12988003">
         <span class="h4">
          Gestational hypertension
         </span>
         <span class="headingEndMark">
          —
         </span>
         A group from the Netherlands assessed the effect of caffeine consumption on maternal cardiovascular changes in a cohort of 7890 pregnant women [
         <a href="#rid117">
          117
         </a>
         ]. Although higher caffeine intake was associated with elevated systolic blood pressure in the first and third trimesters, there was no effect on diastolic blood pressure levels and caffeine consumption appeared to be protective against preeclampsia.
        </p>
        <p class="headingAnchor" id="H10028798">
         <span class="h4">
          Postpartum depression
         </span>
         <span class="headingEndMark">
          —
         </span>
         A study of 662 women recruited within 24 hours of giving birth did not observe an association between prenatal caffeine intake and depressive symptoms postpartum [
         <a href="#rid118">
          118
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          HEALTH IMPACT ON CHILD
         </span>
         <span class="headingEndMark">
          —
         </span>
         The impact of caffeine exposure on neurodevelopment and growth appears to vary by outcome of study and duration of follow-up. Examples include the following studies:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neonatal withdrawal
         </strong>
         – Several case reports describe symptoms of neonatal caffeine withdrawal including irritability, jitteriness, and vomiting. Symptoms began in immediate postnatal period and resolved without intervention within 84 hours. All the cases were associated with heavy prolonged maternal consumption of caffeine [
         <a href="#rid119">
          119,120
         </a>
         ]. There are no data on neonatal withdrawal in mothers consuming fewer than six caffeinated drinks per day.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intelligence Quotient (IQ)
         </strong>
         – Maternal caffeine consumption does not appear to impact offspring IQ. A study of 2197 mother-child pairs reported no association between caffeine exposure in the second and third trimester with childhood IQ or behavior problems at ages four and seven years [
         <a href="#rid121">
          121
         </a>
         ]. The caffeine exposure in this study was assessed by measuring serum paraxanthine levels in women before 20 weeks and after 26 weeks [
         <a href="#rid3">
          3
         </a>
         ]. Similar lack of association was also reported by a secondary analysis in a different prospective study with seven years of follow-up [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overactive behavior
         </strong>
         – The data on the impact of caffeine on childhood overactive behavior are conflicting and may be dose-related. In one prospective study of over 25,000 mother-child pairs that reported an association between caffeine consumption and overactive behavior in children aged 18 months, the association only held for intrauterine exposure to soft drinks and not for coffee [
         <a href="#rid123">
          123
         </a>
         ]. A prospective cohort study that assessed maternal caffeine consumption by self-report and measured childhood behavior at five to six years (over 3400 children) reported no association between maternal caffeine and behavior disorders. In contrast, in the largest study from the Danish National Birth Cohort of over 47,000 children born between 1996 and 2002, maternal consumption of 8 or more cups of coffee or tea per day at 15 weeks of gestation was associated with increased risks of behavioral disorders in children at 11 years of age [
         <a href="#rid124">
          124
         </a>
         ]. Excessive coffee consumption was associated with a 50 percent increased risk of hyperactivity-inattention disorder, while excessive tea consumption was associated with a 28 percent increased risk of anxiety-depressive disorders and 24 percent increased risk of any psychiatric disorder. Strengths of the study include the older age of the assessed children and large sample size, while the study is limited by use of maternal self-report of caffeine intake. Of note, anxious mothers tend to consume more caffeine, which in itself creates an inherent selection bias or reverse causation. More work with adjustment to maternal emotional status is required to shed light on effect of caffeine consumption on behavioral disorders in offspring.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Childhood growth
         </strong>
         <strong>
          and risk of overweight or obesity
         </strong>
         – Although there are conflicting data, large prospective observational studies have reported an increased risk of high weight gain and elevated body mass index (BMI), as well as shorter height, in children born to mothers who consumed large amounts of caffeine while pregnant [
         <a href="#rid125">
          125-130
         </a>
         ]. Although potential mechanisms are not yet understood, these data provide further rationale to limit caffeine intake while pregnant.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Increased childhood weight gain
         </strong>
         – In a prospective Norwegian cohort study of nearly 51,000 mothers with singleton pregnancies, children born to women with average (50 to 199 mg/day), high (≥200 to 299 mg/day), and very high (≥300 mg/day) caffeine intake during pregnancy had an increased risk of excess weight gain (defined as gender-adjusted World Health Organization weight-for-ages Z-score of &gt;0.67) during infancy and early childhood when compared with children born to women with low caffeine intake (&lt;50 mg/day) in adjusted analysis [
         <a href="#rid131">
          131
         </a>
         ]. The odds of being overweight at three and five years rose with increasing maternal caffeine consumption (odds ratios 1.15 (95% CI 1.09-1.22), 1.30, (95% CI 1.16-1.45), and 1.66 (95% CI 1.42-1.93), respectively. There was also a linear association between maternal caffeine consumption and the risk of having an overweight or obese child (as determined by body mass index) with similar findings for caffeine from different caffeine sources (black coffee, black tea, and soda drinks). By eight years of age, only children of very high caffeine exposure mothers continued to have an increased risk of being overweight or obese. In subgroup analysis that excluded the highest caffeine consumption group, caffeine intake of &lt;300 mg/day was still associated with increased infant growth and overweight when compared with women who did not consume caffeine and there was no threshold effect for safety. Adjusted variables included maternal age, maternal education, parity, prepregnancy BMI, paternal BMI, maternal and paternal smoking during pregnancy, maternal energy intake and nausea/vomiting during pregnancy, as well as gestational age and child's gender. Although prenatal caffeine exposure is generally associated with an increased risk of lower birth weight [
         <a href="#rid104">
          104,132
         </a>
         ], in utero caffeine exposure is thought to increase postnatal growth through alterations in fetal programming [
         <a href="#rid133">
          133,134
         </a>
         ]. However, a subsequent smaller prospective observational study that followed children up to age eight years did not observe an association between maternal caffeine consumption and childhood BMI, fat mass, or fat percentage [
         <a href="#rid130">
          130
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Shorter childhood height
         </strong>
         – A prospective observational study including two different cohorts of children (n = 788 and 1622) reported that higher maternal caffeine consumption was associated with shorter childhood stature [
         <a href="#rid130">
          130
         </a>
         ]. The finding was present across all quartiles of caffeine exposure, dose-related, and persisted up to eight years of life. At four to eight years, height differences were between 0.68 to 2.2 cm, similar to the results from women who smoked in pregnancy [
         <a href="#rid130">
          130
         </a>
         ]. As in previous studies, there was insufficient detail on potential confounding factors such as maternal diet, nausea and vomiting in early pregnancy, or paternal factors.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other
         </strong>
         – In addition to childhood growth and general development, associations between in utero caffeine exposure and leukemia, testicular cancer, sudden infant death syndrome, and brain development in offspring have been evaluated, but the available data are either inconclusive or of unclear clinical significance [
         <a href="#rid135">
          135-139
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h1">
          LACTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Caffeine is detectable in breast milk within 15 minutes of consumption and levels peak after approximately one hour [
         <a href="#rid140">
          140
         </a>
         ]. Maternal caffeine consumption of 500 mg/day results in daily infant caffeine intake ranging from 0.3 to 1.0 mg/kg body weight; after maternal consumption of up to 335 mg of caffeine, the amount available through breast milk has been estimated at less than 2 mg per 24 hour period [
         <a href="#rid141">
          141
         </a>
         ]. Adverse effects have not been reported in term infants whose mothers had moderate intake of three to five cups of coffee daily, but some case reports have described an increase in infant irritability, jitteriness, or sleep disturbance beyond this level of maternal caffeine consumption [
         <a href="#rid78">
          78,142,143
         </a>
         ]. In one of the larger series (n = 885 infants), heavy (≥300 mg/day) maternal caffeine consumption during pregnancy and three months postpartum by breastfeeding mothers was associated with an increase in the percentage of infants with frequent (&gt;3 times per night) nocturnal wakening (19.5 versus 13.3 percent with non-heavy or no maternal caffeine consumption; RR 1.65, 95% CI 0.86-3.17), but the difference was not statistically significant [
         <a href="#rid144">
          144
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h1">
          RECOMMENDATIONS OF SOCIETIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         No uniform counseling guidelines or evidence-based recommendations for caffeine intake are available. Many medical societies and government bodies recommend limiting caffeine intake in pregnancy to 200 to 300 mg per day (
         <a class="graphic graphic_table graphicRef134407" href="/z/d/graphic/134407.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid55">
          55-60,63,145
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1444114699">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112560.html" rel="external">
          "Society guideline links: General prenatal care"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Common sources of caffeine
         </strong>
         – In many countries, the main source of caffeine is coffee, followed by tea and caffeinated beverages (
         <a class="graphic graphic_table graphicRef79304" href="/z/d/graphic/79304.html" rel="external">
          table 1
         </a>
         ). Examples of the caffeine content of various beverages are shown in the table (
         <a class="graphic graphic_table graphicRef79304" href="/z/d/graphic/79304.html" rel="external">
          table 1
         </a>
         ) and available at
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cspinet.org%2Fcaffeine-chart&amp;token=F2fTJXWTbAdqtiUVhUGfETonFbU9J8e0isoGIp%2FtZXVhhzwc2z2zYwFU7hTmtZz7&amp;TOPIC_ID=406" target="_blank">
          http://www.cspinet.org/new/cafchart.htm
         </a>
         . (See
         <a class="local">
          'Sources of caffeine'
         </a>
         above and
         <a class="local">
          'Recommendations of societies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Maternal caffeine metabolism and fetal impact
         </strong>
         – Maternal caffeine metabolism declines significantly during pregnancy. Caffeine and its metabolites readily cross the placenta and can be found in substantial quantities in the amniotic fluid and fetal blood. Higher maternal plasma caffeine levels appear to be associated with a longer duration of fetal arousal, increased fetal heart rate variability, lower basal fetal heart rate, increased fetal breathing activity, and inconsistent effects on fetal and placental blood flow. (See
         <a class="local">
          'Maternal and fetal kinetics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Data limitations and patient guidance
         </strong>
         – Given the limitations and inconsistencies of available data, we suggest individuals who are attempting to conceive or who are pregnant or breastfeeding limit caffeine consumption to less than 200 to 300 mg per day until more conclusive data are available (
         <a class="graphic graphic_table graphicRef134407" href="/z/d/graphic/134407.html" rel="external">
          table 2
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Although there is ongoing controversy regarding the safety of caffeine, most studies on the topic, and resultant recommendations, provide reassurance that small to moderate amounts of caffeine are unlikely to harm the pregnancy. (See
         <a class="local">
          'Quality of existing evidence and methodologic considerations'
         </a>
         above and
         <a class="local">
          'Recommendations of societies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Fertility and pregnancy outcomes
         </strong>
         – At typical levels of caffeine intake (up to 300 mg per day from all sources), there does not appear to be a convincing association between caffeine consumption and fecundability or adverse reproductive events, including congenital anomalies, spontaneous abortion, fetal growth restriction, and preterm birth. (See
         <a class="local">
          'Fertility'
         </a>
         above and
         <a class="local">
          'Fetal outcomes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Maternal outcomes
         </strong>
         – Periconceptional moderate coffee intake appears to protect against development of gestational diabetes mellitus. (See
         <a class="local">
          'Gestational diabetes mellitus'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Childhood outcomes
         </strong>
         – Maternal caffeine consumption can result in neonatal withdrawal. Higher levels of maternal consumption have been associated with childhood behavioral and growth changes, although available data conflict. (See
         <a class="local">
          'Health impact on child'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Grosso LM, Bracken MB. Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 2005; 15:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doepker C, Lieberman HR, Smith AP, et al. Caffeine: Friend or Foe? Annu Rev Food Sci Technol 2016; 7:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frary CD, Johnson RK, Wang MQ. Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 2005; 105:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Derbyshire E, Abdula S. Habitual caffeine intake in women of childbearing age. J Hum Nutr Diet 2008; 21:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamada M, Sasaki S, Murakami K, et al. Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populations. Public Health Nutr 2010; 13:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knight CA, Knight I, Mitchell DC, Zepp JE. Beverage caffeine intake in US consumers and subpopulations of interest: estimates from the Share of Intake Panel survey. Food Chem Toxicol 2004; 42:1923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boylan SM, Cade JE, Kirk SF, et al. Assessing caffeine exposure in pregnant women. Br J Nutr 2008; 100:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darakjian LI, Kaddoumi A. Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Caffeine Disposition in Pregnancy. Mol Pharm 2019; 16:1340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sasaki S, Limpar M, Sata F, et al. Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study. Pediatr Res 2017; 82:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nehlig A. Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption. Pharmacol Rev 2018; 70:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang-Liu DD, Williams RL, Riegelman S. Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 1983; 224:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Signorello LB, Nordmark A, Granath F, et al. Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses. Obstet Gynecol 2001; 98:1059.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sata F, Yamada H, Suzuki K, et al. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod 2005; 11:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tanaka H, Nakazawa K, Arima M, Iwasaki S. Caffeine and its dimethylxanthines and fetal cerebral development in rat. Brain Dev 1984; 6:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aldridge A, Bailey J, Neims AH. The disposition of caffeine during and after pregnancy. Semin Perinatol 1981; 5:310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu T, Campbell SC, Stockmann C, et al. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites. J Clin Pharmacol 2016; 56:590.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirkinen P, Jouppila P, Koivula A, et al. The effect of caffeine on placental and fetal blood flow in human pregnancy. Am J Obstet Gynecol 1983; 147:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soyka LF. Effects of methylxanthines on the fetus. Clin Perinatol 1979; 6:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsubouchi H, Shimoya K, Hayashi S, et al. Effect of coffee intake on blood flow and maternal stress during the third trimester of pregnancy. Int J Gynaecol Obstet 2006; 92:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wenstrom KD, Johanning GL, Johnston KE, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001; 184:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhoef P, Pasman WJ, Van Vliet T, et al. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr 2002; 76:1244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu YA, Ostlund E, Fried G. Endothelin-induced contractions in human placental blood vessels are enhanced in intrauterine growth retardation, and modulated by agents that regulate levels of intracellular calcium. Acta Physiol Scand 1995; 155:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manderson JG, Mullan B, Patterson CC, et al. Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy. Diabetologia 2002; 45:991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sowers MR, Crawford S, McConnell DS, et al. Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women. J Nutr 2006; 136:1588.
          </a>
         </li>
         <li class="breakAll">
          National Health and Medical Research Council. A guide to the development, implementation and evaluation of clinical practice guidelines. NHMRC 1999.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brent RL, Christian MS, Diener RM. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol 2011; 92:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peck JD, Leviton A, Cowan LD. A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update. Food Chem Toxicol 2010; 48:2549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stein Z, Susser M. Miscarriage, caffeine, and the epiphenomena of pregnancy: the causal model. Epidemiology 1991; 2:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harland BF. Caffeine and nutrition. Nutrition 2000; 16:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. J Anal Toxicol 2003; 27:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crozier TW, Stalmach A, Lean ME, Crozier A. Espresso coffees, caffeine and chlorogenic acid intake: potential health implications. Food Funct 2012; 3:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weng X, Odouli R, Li DK. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008; 198:279.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 2008; 337:a2332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grosso LM, Triche E, Benowitz NL, Bracken MB. Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake? Ann Epidemiol 2008; 18:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savitz DA, Chan RL, Herring AH, et al. Caffeine and miscarriage risk. Epidemiology 2008; 19:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage--results from a UK-population-based case-control study. BJOG 2007; 114:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furneaux EC, Langley-Evans AJ, Langley-Evans SC. Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Surv 2001; 56:775.
          </a>
         </li>
         <li class="breakAll">
          US Department of Agriculture Agricultural Research Service. USDA National Nutrient Database for Standard Reference, release 21. http://www.ars.usda.gov/nutrientdata. (Accessed on July 06, 2009).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nehlig A, Debry G. Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data. Neurotoxicol Teratol 1994; 16:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NISHIMURA H, NAKAI K. Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Biol Med 1960; 104:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scott WJ Jr. Caffeine-induced limb malformations: description of malformations and quantitation of placental transfer. Teratology 1983; 28:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moriguchi M, Scott WJ Jr. Prevention of caffeine-induced limb malformations by maternal adrenalectomy. Teratology 1986; 33:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li XD, He RR, Qin Y, et al. Caffeine interferes embryonic development through over-stimulating serotonergic system in chicken embryo. Food Chem Toxicol 2012; 50:1848.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma ZL, Qin Y, Wang G, et al. Exploring the caffeine-induced teratogenicity on neurodevelopment using early chick embryo. PLoS One 2012; 7:e34278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marret S, Gressens P, Van-Maele-Fabry G, et al. Caffeine-induced disturbances of early neurogenesis in whole mouse embryo cultures. Brain Res 1997; 773:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkinson JM, Pollard I. In utero exposure to caffeine causes delayed neural tube closure in rat embryos. Teratog Carcinog Mutagen 1994; 14:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gross C, Zhuang X, Stark K, et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002; 416:396.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol 2004; 190 Suppl 1:S8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinstock M. Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis? Neurosci Biobehav Rev 1997; 21:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang J, Zhou S, Ping J, et al. Role of p53-dependent placental apoptosis in the reproductive and developmental toxicities of caffeine in rodents. Clin Exp Pharmacol Physiol 2012; 39:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharmin S, Guan H, Williams AS, Yang K. Caffeine reduces 11β-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through the adenosine A(2B) receptor. PLoS One 2012; 7:e38082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shams M, Kilby MD, Somerset DA, et al. 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998; 13:799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grant I, Cartwright JE, Lumicisi B, et al. Caffeine inhibits EGF-stimulated trophoblast cell motility through the inhibition of mTORC2 and Akt. Endocrinology 2012; 153:4502.
          </a>
         </li>
         <li class="breakAll">
          Scientific opinion on the safety of caffeine. EFSA Panel on Dietetic Products, Nutrition and Allergies. European Food Safety Authority (EFSA), Parma, Italy. 2015. https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2015.4102 (Accessed on November 17, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy. Obstet Gynecol 2010; 116:467. Reaffirmed 2023.
          </a>
         </li>
         <li class="breakAll">
          Caffeine. Health Direct. Australian Government Department of Health. https://www.healthdirect.gov.au/caffeine (Accessed on September 18, 2020).
         </li>
         <li class="breakAll">
          Caffeine in pregnancy. March of Dimes. April 2020. https://www.marchofdimes.org/pregnancy/caffeine-in-pregnancy.aspx# (Accessed on November 17, 2021).
         </li>
         <li class="breakAll">
          Caffeine and pregnancy. Public Health Agency of Canada. January 2020. https://www.canada.ca/en/public-health/services/pregnancy/caffeine.html (Accessed on November 17, 2021).
         </li>
         <li class="breakAll">
          Food additives. Food Standards Agency. Gov.uk. October 2019. https://www.food.gov.uk/safety-hygiene/food-additives (Accessed on November 17, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brito Nunes C, Huang P, Wang G, et al. Mendelian randomization study of maternal coffee consumption and its influence on birthweight, stillbirth, miscarriage, gestational age and pre-term birth. Int J Epidemiol 2023; 52:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jahanfar S, Jaafar SH. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. Cochrane Database Syst Rev 2015; :CD006965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wikoff D, Welsh BT, Henderson R, et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol 2017; 109:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James JE. Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be. BMJ Evid Based Med 2021; 26:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Homan GF, Davies M, Norman R. The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review. Hum Reprod Update 2007; 13:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility. Optimizing natural fertility: a committee opinion. Fertil Steril 2013; 100:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilcox A, Weinberg C, Baird D. Caffeinated beverages and decreased fertility. Lancet 1988; 2:1453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bolúmar F, Olsen J, Rebagliato M, Bisanti L. Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity. Am J Epidemiol 1997; 145:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hassan MA, Killick SR. Negative lifestyle is associated with a significant reduction in fecundity. Fertil Steril 2004; 81:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility. Epidemiology 2009; 20:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor KC, Small CM, Dominguez CE, et al. alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2. Ann Epidemiol 2011; 21:864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caan B, Quesenberry CP Jr, Coates AO. Differences in fertility associated with caffeinated beverage consumption. Am J Public Health 1998; 88:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Florack EI, Zielhuis GA, Rolland R. Cigarette smoking, alcohol consumption, and caffeine intake and fecundability. Prev Med 1994; 23:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen TK, Henriksen TB, Hjollund NH, et al. Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy. Reprod Toxicol 1998; 12:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hatch EE, Wise LA, Mikkelsen EM, et al. Caffeinated beverage and soda consumption and time to pregnancy. Epidemiology 2012; 23:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klonoff-Cohen H, Bleha J, Lam-Kruglick P. A prospective study of the effects of female and male caffeine consumption on the reproductive endpoints of IVF and gamete intra-Fallopian transfer. Hum Reprod 2002; 17:1746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Saleh I, El-Doush I, Grisellhi B, Coskun S. The effect of caffeine consumption on the success rate of pregnancy as well various performance parameters of in-vitro fertilization treatment. Med Sci Monit 2010; 16:CR598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006; 46:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ricci E, Viganò P, Cipriani S, et al. Coffee and caffeine intake and male infertility: a systematic review. Nutr J 2017; 16:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salas-Huetos A, Bulló M, Salas-Salvadó J. Dietary patterns, foods and nutrients in male fertility parameters and fecundability: a systematic review of observational studies. Hum Reprod Update 2017; 23:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karmon AE, Toth TL, Chiu YH, et al. Male caffeine and alcohol intake in relation to semen parameters and in vitro fertilization outcomes among fertility patients. Andrology 2017; 5:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klebanoff MA, Levine RJ, DerSimonian R, et al. Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion. N Engl J Med 1999; 341:1639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howards PP, Hertz-Picciotto I, Bech BH, et al. Spontaneous abortion and a diet drug containing caffeine and ephedrine: a study within the Danish national birth cohort. PLoS One 2012; 7:e50372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buck Louis GM, Sapra KJ, Schisterman EF, et al. Lifestyle and pregnancy loss in a contemporary cohort of women recruited before conception: The LIFE Study. Fertil Steril 2016; 106:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hahn KA, Wise LA, Rothman KJ, et al. Caffeine and caffeinated beverage consumption and risk of spontaneous abortion. Hum Reprod 2015; 30:1246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulder EJ, Tegaldo L, Bruschettini P, Visser GH. Foetal response to maternal coffee intake: role of habitual versus non-habitual caffeine consumption. J Psychopharmacol 2010; 24:1641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devoe LD, Murray C, Youssif A, Arnaud M. Maternal caffeine consumption and fetal behavior in normal third-trimester pregnancy. Am J Obstet Gynecol 1993; 168:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGowan J, Devoe LD, Searle N, Altman R. The effects of long- and short-term maternal caffeine ingestion on human fetal breathing and body movements in term gestations. Am J Obstet Gynecol 1987; 157:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salvador HS, Koos BJ. Effects of regular and decaffeinated coffee on fetal breathing and heart rate. Am J Obstet Gynecol 1989; 160:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buscicchio G, Piemontese M, Gentilucci L, et al. The effects of maternal caffeine and chocolate intake on fetal heart rate. J Matern Fetal Neonatal Med 2012; 25:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Addit Contam 2003; 20:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Browne ML. Maternal exposure to caffeine and risk of congenital anomalies: a systematic review. Epidemiology 2006; 17:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williford EM, Howley MM, Fisher SC, et al. Maternal dietary caffeine consumption and risk of birth defects in the National Birth Defects Prevention Study, 1997-2011. Birth Defects Res 2023; 115:921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin TR, Bracken MB. The association between low birth weight and caffeine consumption during pregnancy. Am J Epidemiol 1987; 126:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fortier I, Marcoux S, Beaulac-Baillargeon L. Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth. Am J Epidemiol 1993; 137:931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fenster L, Eskenazi B, Windham GC, Swan SH. Caffeine consumption during pregnancy and fetal growth. Am J Public Health 1991; 81:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jarosz M, Wierzejska R, Siuba M. Maternal caffeine intake and its effect on pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2012; 160:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clausson B, Granath F, Ekbom A, et al. Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am J Epidemiol 2002; 155:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grosso LM, Rosenberg KD, Belanger K, et al. Maternal caffeine intake and intrauterine growth retardation. Epidemiology 2001; 12:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parazzini F, Chiaffarino F, Chatenoud L, et al. Maternal coffee drinking in pregnancy and risk of small for gestational age birth. Eur J Clin Nutr 2005; 59:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santos IS, Matijasevich A, Valle NC. Mate drinking during pregnancy and risk of preterm and small for gestational age birth. J Nutr 2005; 135:1120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen LW, Fitzgerald R, Murrin CM, et al. Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study. Am J Clin Nutr 2018; 108:1301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen LW, Wu Y, Neelakantan N, et al. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis. BMC Med 2014; 12:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rhee J, Kim R, Kim Y, et al. Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies. PLoS One 2015; 10:e0132334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bech BH, Obel C, Henriksen TB, Olsen J. Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. BMJ 2007; 334:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gleason JL, Tekola-Ayele F, Sundaram R, et al. Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons. JAMA Netw Open 2021; 4:e213238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maslova E, Bhattacharya S, Lin SW, Michels KB. Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis. Am J Clin Nutr 2010; 92:1120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matijasevich A, Santos IS, Barros FC. Does caffeine consumption during pregnancy increase the risk of fetal mortality? A literature review. Cad Saude Publica 2005; 21:1676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adeney KL, Williams MA, Schiff MA, et al. Coffee consumption and the risk of gestational diabetes mellitus. Acta Obstet Gynecol Scand 2007; 86:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hinkle SN, Laughon SK, Catov JM, et al. First trimester coffee and tea intake and risk of gestational diabetes mellitus: a study within a national birth cohort. BJOG 2015; 122:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hinkle SN, Gleason JL, Yisahak SF, et al. Assessment of Caffeine Consumption and Maternal Cardiometabolic Pregnancy Complications. JAMA Netw Open 2021; 4:e2133401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tunnicliffe JM, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008; 33:1290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beaudoin MS, Graham TE. Methylxanthines and human health: epidemiological and experimental evidence. Handb Exp Pharmacol 2011; :509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson LE, Spafford C, Graham TE, Smith GN. Acute caffeine ingestion and glucose tolerance in women with or without gestational diabetes mellitus. J Obstet Gynaecol Can 2009; 31:304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biaggioni I, Davis SN. Caffeine: a cause of insulin resistance? Diabetes Care 2002; 25:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laughon SK, Powers RW, Roberts JM, et al. Caffeine and insulin resistance in pregnancy. Am J Perinatol 2011; 28:571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bakker R, Steegers EA, Raat H, et al. Maternal caffeine intake, blood pressure, and the risk of hypertensive complications during pregnancy. The Generation R Study. Am J Hypertens 2011; 24:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dagher RK, Shenassa ED. Prenatal health behaviors and postpartum depression: is there an association? Arch Womens Ment Health 2012; 15:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGowan JD, Altman RE, Kanto WP Jr. Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine. South Med J 1988; 81:1092.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martín I, López-Vílchez MA, Mur A, et al. Neonatal withdrawal syndrome after chronic maternal drinking of mate. Ther Drug Monit 2007; 29:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klebanoff MA, Keim SA. Maternal Caffeine Intake During Pregnancy and Child Cognition and Behavior at 4 and 7 Years of Age. Am J Epidemiol 2015; 182:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barr HM, Streissguth AP. Caffeine use during pregnancy and child outcome: a 7-year prospective study. Neurotoxicol Teratol 1991; 13:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bekkhus M, Skjøthaug T, Nordhagen R, Borge AI. Intrauterine exposure to caffeine and inattention/overactivity in children. Acta Paediatr 2010; 99:925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mikkelsen SH, Obel C, Olsen J, et al. Maternal caffeine consumption during pregnancy and behavioral disorders in 11-year-old offspring: A Danish nation birth cohort study. J Pediatr 2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Medeiros TS, Bernardi JR, de Brito ML, et al. Caffeine Intake During Pregnancy in Different Intrauterine Environments and its Association with Infant Anthropometric Measurements at 3 and 6 Months of Age. Matern Child Health J 2017; 21:1297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voerman E, Jaddoe VW, Gishti O, et al. Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age. Obesity (Silver Spring) 2016; 24:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li DK, Ferber JR, Odouli R. Maternal caffeine intake during pregnancy and risk of obesity in offspring: a prospective cohort study. Int J Obes (Lond) 2015; 39:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen LW, Murrin CM, Mehegan J, et al. Maternal, but not paternal or grandparental, caffeine intake is associated with childhood obesity and adiposity: The Lifeways Cross-Generation Cohort Study. Am J Clin Nutr 2019; 109:1648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Voerman E, Jaddoe VW, Hulst ME, et al. Associations of maternal caffeine intake during pregnancy with abdominal and liver fat deposition in childhood. Pediatr Obes 2020; 15:e12607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gleason JL, Sundaram R, Mitro SD, et al. Association of Maternal Caffeine Consumption During Pregnancy With Child Growth. JAMA Netw Open 2022; 5:e2239609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papadopoulou E, Botton J, Brantsæter AL, et al. Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study. BMJ Open 2018; 8:e018895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sengpiel V, Elind E, Bacelis J, et al. Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. BMC Med 2013; 11:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barker DJ. In utero programming of chronic disease. Clin Sci (Lond) 1998; 95:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maffeis C, Morandi A. Effect of Maternal Obesity on Foetal Growth and Metabolic Health of the Offspring. Obes Facts 2017; 10:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mongraw-Chaffin ML, Cohn BA, Cohen RD, Christianson RE. Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959-1967. Am J Epidemiol 2008; 167:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mongraw-Chaffin ML, Cohn BA, Anglemyer AT, et al. Maternal smoking, alcohol, and coffee use during pregnancy and son's risk of testicular cancer. Alcohol 2009; 43:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ford RP, Schluter PJ, Mitchell EA, et al. Heavy caffeine intake in pregnancy and sudden infant death syndrome. New Zealand Cot Death Study Group. Arch Dis Child 1998; 78:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng J, Su H, Zhu R, et al. Maternal coffee consumption during pregnancy and risk of childhood acute leukemia: a metaanalysis. Am J Obstet Gynecol 2014; 210:151.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christensen ZP, Freedman EG, Foxe JJ. Caffeine exposure in utero is associated with structural brain alterations and deleterious neurocognitive outcomes in 9-10 year old children. Neuropharmacology 2021; 186:108479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berlin CM Jr, Denson HM, Daniel CH, Ward RM. Disposition of dietary caffeine in milk, saliva, and plasma of lactating women. Pediatrics 1984; 73:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryu JE. Caffeine in human milk and in serum of breast-fed infants. Dev Pharmacol Ther 1985; 8:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rivera-calimlim L. Drugs in breast milk. Drug Ther (NY) 1977; 7:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caffeine and babies. BMJ 1989; 299:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santos IS, Matijasevich A, Domingues MR. Maternal caffeine consumption and infant nighttime waking: prospective cohort study. Pediatrics 2012; 129:860.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenwood DC, Thatcher NJ, Ye J, et al. Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. Eur J Epidemiol 2014; 29:725.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 406 Version 38.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15967394" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26735800" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Caffeine: Friend or Foe?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15635355" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Food sources and intakes of caffeine in the diets of persons in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18339056" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Habitual caffeine intake in women of childbearing age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20082748" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15500929" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Beverage caffeine intake in US consumers and subpopulations of interest: estimates from the Share of Intake Panel survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18331663" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Assessing caffeine exposure in pregnant women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30689395" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Caffeine Disposition in Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28355205" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Interaction between maternal caffeine intake during pregnancy and CYP1A2 C164A polymorphism affects infant birth size in the Hokkaido study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29514871" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6848742" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Disposition of caffeine and its metabolites in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11755554" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Caffeine metabolism and the risk of spontaneous abortion of normal karyotype fetuses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15849225" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6496872" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Caffeine and its dimethylxanthines and fetal cerebral development in rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7302604" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The disposition of caffeine during and after pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26358647" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6650631" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : The effect of caffeine on placental and fetal blood flow in human pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/225087" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Effects of methylxanthines on the fetus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16242134" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Effect of coffee intake on blood flow and maternal stress during the third trimester of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7741859" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Homocysteine metabolism in pregnancies complicated by neural-tube defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11303187" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12450889" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8719260" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Endothelin-induced contractions in human placental blood vessels are enhanced in intrauterine growth retardation, and modulated by agents that regulate levels of intracellular calcium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12136397" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Cardiovascular and metabolic abnormalities in the offspring of diabetic pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16702326" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16702326" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Selected diet and lifestyle factors are associated with estrogen metabolites in a multiracial/ethnic population of women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21370398" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Evaluation of the reproductive and developmental risks of caffeine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20558227" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: a 2000-2009 update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2054396" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Miscarriage, caffeine, and the epiphenomena of pregnancy: the causal model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10906543" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Caffeine and nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14607010" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Caffeine content of specialty coffees.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22130653" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Espresso coffees, caffeine and chlorogenic acid intake: potential health implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18221932" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18981029" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18083538" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prenatal caffeine assessment: fetal and maternal biomarkers or self-reported intake?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18091004" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Caffeine and miscarriage risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17305901" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Risk factors for first trimester miscarriage--results from a UK-population-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11753180" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11753180" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7862054" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: a review on human and animal data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14427313" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Congenital malformations in offspring of mice treated with caffeine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6665741" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Caffeine-induced limb malformations: description of malformations and quantitation of placental transfer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3738825" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Prevention of caffeine-induced limb malformations by maternal adrenalectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22449533" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Caffeine interferes embryonic development through over-stimulating serotonergic system in chicken embryo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22470550" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Exploring the caffeine-induced teratogenicity on neurodevelopment using early chick embryo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9409724" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Caffeine-induced disturbances of early neurogenesis in whole mouse embryo cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7855740" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : In utero exposure to caffeine causes delayed neural tube closure in rat embryos.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11919622" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15498537" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Development of neurotransmitter systems during critical periods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8994205" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22243401" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Role of p53-dependent placental apoptosis in the reproductive and developmental toxicities of caffeine in rodents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22701600" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Caffeine reduces 11β-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through the adenosine A(2B) receptor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9619527" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : 11Beta-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22851680" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Caffeine inhibits EGF-stimulated trophoblast cell motility through the inhibition of mTORC2 and Akt.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22851680" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Caffeine inhibits EGF-stimulated trophoblast cell motility through the inhibition of mTORC2 and Akt.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664420" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664420" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664420" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664420" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20664420" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : ACOG Committee Opinion No. 462: Moderate caffeine consumption during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35679582" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Mendelian randomization study of maternal coffee consumption and its influence on birthweight, stillbirth, miscarriage, gestational age and pre-term birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26058966" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28438661" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32843532" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17208948" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The impact of lifestyle factors on reproductive performance in the general population and those undergoing infertility treatment: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23993665" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Optimizing natural fertility: a committee opinion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2904572" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Caffeinated beverages and decreased fertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9054236" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Caffeine intake and delayed conception: a European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14967378" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Negative lifestyle is associated with a significant reduction in fecundity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19279491" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Caffeinated and alcoholic beverage intake in relation to ovulatory disorder infertility.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21684175" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : alcohol, smoking, and caffeine in relation to fecundability, with effect modification by NAT2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9491020" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Differences in fertility associated with caffeinated beverage consumption.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8047523" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Cigarette smoking, alcohol consumption, and caffeine intake and fecundability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9628552" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Caffeine intake and fecundability: a follow-up study among 430 Danish couples planning their first pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22407137" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Caffeinated beverage and soda consumption and time to pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12093834" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : A prospective study of the effects of female and male caffeine consumption on the reproductive endpoints of IVF and gamete intra-Fallopian transfer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21119578" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : The effect of caffeine consumption on the success rate of pregnancy as well various performance parameters of in-vitro fertilization treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16507475" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Coffee and health: a review of recent human research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28646871" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Coffee and caffeine intake and male infertility: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28333357" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Dietary patterns, foods and nutrients in male fertility parameters and fecundability: a systematic review of observational studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28187518" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Male caffeine and alcohol intake in relation to semen parameters and in vitro fertilization outcomes among fertility patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10572151" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23166844" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Spontaneous abortion and a diet drug containing caffeine and ephedrine: a study within the Danish national birth cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27016456" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Lifestyle and pregnancy loss in a contemporary cohort of women recruited before conception: The LIFE Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25788567" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Caffeine and caffeinated beverage consumption and risk of spontaneous abortion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19506007" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Foetal response to maternal coffee intake: role of habitual versus non-habitual caffeine consumption.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8475956" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Maternal caffeine consumption and fetal behavior in normal third-trimester pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3631173" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : The effects of long- and short-term maternal caffeine ingestion on human fetal breathing and body movements in term gestations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2729379" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Effects of regular and decaffeinated coffee on fetal breathing and heart rate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22502981" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : The effects of maternal caffeine and chocolate intake on fetal heart rate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12519715" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Effects of caffeine on human health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16570025" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Maternal exposure to caffeine and risk of congenital anomalies: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36942611" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Maternal dietary caffeine consumption and risk of birth defects in the National Birth Defects Prevention Study, 1997-2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3661529" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : The association between low birth weight and caffeine consumption during pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8317450" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Relation of caffeine intake during pregnancy to intrauterine growth retardation and preterm birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2003624" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Caffeine consumption during pregnancy and fetal growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22142815" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Maternal caffeine intake and its effect on pregnancy outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11867354" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Effect of caffeine exposure during pregnancy on birth weight and gestational age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11428387" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Maternal caffeine intake and intrauterine growth retardation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15454971" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Maternal coffee drinking in pregnancy and risk of small for gestational age birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15867291" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Mate drinking during pregnancy and risk of preterm and small for gestational age birth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30339199" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Associations of maternal caffeine intake with birth outcomes: results from the Lifeways Cross Generation Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25238871" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Maternal caffeine intake during pregnancy is associated with risk of low birth weight: a systematic review and dose-response meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26193706" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17259189" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33764424" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Association Between Maternal Caffeine Consumption and Metabolism and Neonatal Anthropometry: A Secondary Analysis of the NICHD Fetal Growth Studies-Singletons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20844077" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16410851" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Does caffeine consumption during pregnancy increase the risk of fetal mortality? A literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17364278" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Coffee consumption and the risk of gestational diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24947484" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : First trimester coffee and tea intake and risk of gestational diabetes mellitus: a study within a national birth cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34748005" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Assessment of Caffeine Consumption and Maternal Cardiometabolic Pregnancy Complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19088791" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20859811" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Methylxanthines and human health: epidemiological and experimental evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19497149" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Acute caffeine ingestion and glucose tolerance in women with or without gestational diabetes mellitus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11815519" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Caffeine: a cause of insulin resistance?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21380987" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Caffeine and insulin resistance in pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21164492" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Maternal caffeine intake, blood pressure, and the risk of hypertensive complications during pregnancy. The Generation R Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22215286" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Prenatal health behaviors and postpartum depression: is there an association?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3420441" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17304161" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Neonatal withdrawal syndrome after chronic maternal drinking of mate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26585526" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Maternal Caffeine Intake During Pregnancy and Child Cognition and Behavior at 4 and 7 Years of Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1921923" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Caffeine use during pregnancy and child outcome: a 7-year prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20219037" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Intrauterine exposure to caffeine and inattention/overactivity in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Maternal caffeine consumption during pregnancy and behavioral disorders in 11-year-old offspring: A Danish nation birth cohort study
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28110387" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Caffeine Intake During Pregnancy in Different Intrauterine Environments and its Association with Infant Anthropometric Measurements at 3 and 6 Months of Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27015969" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Maternal caffeine intake during pregnancy, early growth, and body fat distribution at school age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25388405" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Maternal caffeine intake during pregnancy and risk of obesity in offspring: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31136661" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Maternal, but not paternal or grandparental, caffeine intake is associated with childhood obesity and adiposity: The Lifeways Cross-Generation Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31883239" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Associations of maternal caffeine intake during pregnancy with abdominal and liver fat deposition in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36315142" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Association of Maternal Caffeine Consumption During Pregnancy With Child Growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29685923" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23421532" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9680492" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : In utero programming of chronic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28384625" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Effect of Maternal Obesity on Foetal Growth and Metabolic Health of the Offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18024986" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959-1967.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19303242" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Maternal smoking, alcohol, and coffee use during pregnancy and son's risk of testicular cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9534669" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Heavy caffeine intake in pregnancy and sudden infant death syndrome. New Zealand Cot Death Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24060443" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : Maternal coffee consumption during pregnancy and risk of childhood acute leukemia: a metaanalysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33529676" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Caffeine exposure in utero is associated with structural brain alterations and deleterious neurocognitive outcomes in 9-10 year old children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6691042" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Disposition of dietary caffeine in milk, saliva, and plasma of lactating women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4075932" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Caffeine in human milk and in serum of breast-fed infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12336945" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Drugs in breast milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2504321" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Caffeine and babies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22473365" id="rid143" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          144 : Maternal caffeine consumption and infant nighttime waking: prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25179792" id="rid144" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          145 : Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
